Abstract: Povidone iodine oral composition/formulation as a solution for use in oral cavity specifically in the form of throat spray. Specifically disclosed is a Povidone Iodine composition, preparation, and stabilization of aqueous or hydro-alcoholic oral solution. The formulation of the invention has long resident time in hard-to-reach areas of the throat, such as pharynx. The process for manufacturing of stabilized and standardized povidone iodine solution.
| # | Name | Date |
|---|---|---|
| 1 | 202311014439-STATEMENT OF UNDERTAKING (FORM 3) [03-03-2023(online)].pdf | 2023-03-03 |
| 2 | 202311014439-PROVISIONAL SPECIFICATION [03-03-2023(online)].pdf | 2023-03-03 |
| 3 | 202311014439-FORM 1 [03-03-2023(online)].pdf | 2023-03-03 |
| 4 | 202311014439-DRAWINGS [03-03-2023(online)].pdf | 2023-03-03 |
| 5 | 202311014439-DRAWING [15-03-2023(online)].pdf | 2023-03-15 |
| 6 | 202311014439-CORRESPONDENCE-OTHERS [15-03-2023(online)].pdf | 2023-03-15 |
| 7 | 202311014439-COMPLETE SPECIFICATION [15-03-2023(online)].pdf | 2023-03-15 |
| 8 | 202311014439-FORM-9 [06-05-2024(online)].pdf | 2024-05-06 |
| 9 | 202311014439-FORM 18 [22-08-2024(online)].pdf | 2024-08-22 |
| 10 | 202311014439-FORM 18A [21-04-2025(online)].pdf | 2025-04-21 |
| 11 | 202311014439-IntimationUnderRule24C(4).pdf | 2025-11-13 |
| 12 | 202311014439-FORM 3 [14-11-2025(online)].pdf | 2025-11-14 |
| 13 | 202311014439-Response to office action [24-11-2025(online)].pdf | 2025-11-24 |